Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00341822 · ClinicalTrials.gov registry record

Invasive Prenatal Testing Decisions in Pregnancy After Infertility

A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).

Completed
Registry status
200
Enrollment target

NCT00341822 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 200 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00341822 has completed, sponsored by National Human Genome Research Institute (NHGRI).

COMPLETED
Registry status
200 participants
Enrollment target

Study Summary

This study will explore the decision-making experiences of women who are currently pregnant following a period of infertility on whether or not to undergo an invasive prenatal test (IPT) procedure, such as amniocentesis or chorionic villus sampling. Women who become pregnant after infertility often experience heightened anxiety regarding the outcome of the pregnancy. When choosing whether or not to have IPT they are faced with a complex decision, set in the unique context of a pregnancy that they often perceive as exceptionally precarious. Women who are pregnant with their first child after a period of infertility and have made a decision regarding whether or not to undergo IPT may be eligible for this study. Participants complete an online password-protected questionnaire that measures infertility and decision-making variables and explores women's perceptions of the impact of infertility on their IPT decision-making process. The questionnaire covers the following areas: * Subject's demographic information, such as age, marital status, number of children, education, race, ethnicity * Subject's infertility history * Subject's thoughts and feelings about infertility * Subject's thoughts and concerns about other people's (e.g., husband, doctor, other infertile women) opinions about IPT * Subject's decision about whether or not to have IPT and her feelings regarding the decision * The effect of subject's infertility history on her decision to have or not have IPT

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2006-03-29
Est. Completion 2007-12-28

What the Registry Record Tells You About NCT00341822

The ClinicalTrials.gov registry entry for NCT00341822 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00341822 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00341822 about?

NCT00341822 is a clinical study titled "Invasive Prenatal Testing Decisions in Pregnancy After Infertility". This study will explore the decision-making experiences of women who are currently pregnant following a period of infertility on whether or not to undergo an invasive prenatal test (IPT) procedure, such as amniocentesis or chorionic villus sampling. Women who become pregnant after infertility often ...

What is the current status of trial NCT00341822?

This trial is currently completed. The enrollment target is 200 participants. The study started on 2006-03-29. Estimated completion is 2007-12-28.

Who is sponsoring clinical trial NCT00341822?

This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.